ENTITY
Torrent Pharmaceuticals

Torrent Pharmaceuticals (TRP IN)

116
Analysis
Health CareIndia
Torrent Pharmaceuticals Ltd. manufactures bulk drugs and pharmaceutical formulations. The Company's formulations include cardio-vascular, psychotropic and anti-biotic drugs while its bulk drugs include atenolol, ciprofloxacin and norfloxacin. Torrent Pharmaceuticals has wholly owned subsidiaries in several regulated and less regulated international markets.
more
bearishMankind Pharma
20 Apr 2023 16:12

Mankind Pharma IPO: Valuation Insights

Our valuation analysis suggests that Mankind Pharma is fully valued at the IPO price range. Therefore, we are inclined to pass on this IPO.

Logo
441 Views
Share
bearishMankind Pharma
19 Apr 2023 16:00

Mankind Pharma IPO: Updates Warrant Caution

The 9MFY23 (nine months to December) disclosure showcases a slowdown in growth, market share losses, margin pressure and declining RoCE. We are...

Logo
383 Views
Share
bullishMankind Pharma
19 Apr 2023 12:18

Mankind Pharma IPO - Quality Name but Might Not Have a Whole Lot of Upside

Mankind Pharma (MP) is looking to raise up to US$527m in its upcoming India IPO. In this note, we talk about the implied valuations.

Logo
402 Views
Share
bullishIndegene
19 Apr 2023 10:51

Indegene Pre-IPO - Growing Client Base and Cross/Up-Selling Led to Growth

Indegene Limited (1864095D IN) is looking to raise about US$400m in its upcoming India IPO. Indegene is a “digital-first” commercialisation firm...

Logo
493 Views
Share
bullishMankind Pharma
18 Apr 2023 17:04

Mankind Pharma Pre-IPO - RHP Updates - A Mixed Bag

Mankind Pharma  (MP) is now looking to raise around US$500m in its upcoming India IPO. In this note we talk about the updates from its recently...

Logo
350 Views
Share
x